Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,2,3,4-Tetrahydroquinolin-2-one is a chemical compound belonging to the quinolinone family. It is an off-white crystalline powder with potential applications in various fields due to its unique chemical properties.

553-03-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 553-03-7 Structure
  • Basic information

    1. Product Name: dihydroquinolinone
    2. Synonyms: HYDROCARBOSTYRIL;DIHYDROCARBOSTYRIL;3,4-DIHYDRO-2(H)-QUINOLINE;3,4-DIHYDRO-2(1H)-QUINOLINONE;3,4-DIHYDRO-2(1H)-QUINOLONE;3,4-DIHYDRO-1H-QUINOLIN-2-ONE;1,2,3,4-Tetrahydroquinolin-2-one;2-OXO-1,2,3,4-TETRAHYDROQUINOLINE
    3. CAS NO:553-03-7
    4. Molecular Formula: C9H9NO
    5. Molecular Weight: 147.17
    6. EINECS: 1592732-453-0
    7. Product Categories: Heterocycles;pharmacetical;API intermediates;Quinolines, Isoquinolines & Quinoxalines
    8. Mol File: 553-03-7.mol
  • Chemical Properties

    1. Melting Point: 165-167 °C(lit.)
    2. Boiling Point: 267.28°C (rough estimate)
    3. Flash Point: 189.4 °C
    4. Appearance: Off-white/Crystalline Powder
    5. Density: 1.1135 (rough estimate)
    6. Vapor Pressure: 0.000194mmHg at 25°C
    7. Refractive Index: 1.5200 (estimate)
    8. Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. PKA: 14.76±0.20(Predicted)
    11. Water Solubility: Slightly soluble in water.
    12. Sensitive: Light Sensitive
    13. Merck: 13,4800
    14. CAS DataBase Reference: dihydroquinolinone(CAS DataBase Reference)
    15. NIST Chemistry Reference: dihydroquinolinone(553-03-7)
    16. EPA Substance Registry System: dihydroquinolinone(553-03-7)
  • Safety Data

    1. Hazard Codes: Xn,Xi
    2. Statements: 22-36/37/38-43
    3. Safety Statements: 26-36/37
    4. RIDADR: 2811
    5. WGK Germany: 2
    6. RTECS:
    7. HazardClass: 6.1(b)
    8. PackingGroup: III
    9. Hazardous Substances Data: 553-03-7(Hazardous Substances Data)

553-03-7 Usage

Uses

Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydroquinolin-2-one is used as a starting material for the synthesis of various biologically active compounds, including potent bicyclic peptide deformylase inhibitors with antibacterial effects. These inhibitors can be employed in the development of new antibiotics to combat drug-resistant bacterial infections.
Used in Enrichment Culture Experiments:
In the field of microbiology, 1,2,3,4-Tetrahydroquinolin-2-one is used as a medium supplement in the culture medium of Pseudomonas ayucida during enrichment culture experiments. This application aids in the growth and isolation of specific bacterial strains for further study and potential applications.
Used in the Synthesis of Inhibitors:
1,2,3,4-Tetrahydroquinolin-2-one is also used to synthesize substituted iminopiperidines, which act as inhibitors of human nitric oxide synthase isoforms. These inhibitors have potential applications in the treatment of various diseases and conditions related to the nitric oxide pathway, such as inflammation, hypertension, and neurodegenerative disorders.
Used in the Synthesis of σ1 Receptor Antagonists:
A series of 3,4-dihydro-2(1H)-quinolinone derivatives with sigma-1 receptor (σ1R) antagonist activity have been synthesized using 1,2,3,4-Tetrahydroquinolin-2-one as a starting reagent. These σ1R antagonists have potential applications in the treatment of various neurological and psychiatric disorders, such as depression, anxiety, and neuropathic pain.

Synthesis Reference(s)

Journal of the American Chemical Society, 89, p. 7131, 1967 DOI: 10.1021/ja01002a061Tetrahedron Letters, 36, p. 125, 1995 DOI: 10.1016/0040-4039(94)02191-D

Check Digit Verification of cas no

The CAS Registry Mumber 553-03-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 553-03:
(5*5)+(4*5)+(3*3)+(2*0)+(1*3)=57
57 % 10 = 7
So 553-03-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-4H,5-6H2,(H,10,11)

553-03-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (415936)  3,4-Dihydro-2(1H)-quinolinone  98%

  • 553-03-7

  • 415936-1G

  • 563.94CNY

  • Detail
  • Aldrich

  • (415936)  3,4-Dihydro-2(1H)-quinolinone  98%

  • 553-03-7

  • 415936-10G

  • 2,726.10CNY

  • Detail

553-03-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2,3,4-Tetrahydroquinolin-2-one

1.2 Other means of identification

Product number -
Other names 3,4-dihydro-1H-quinolin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:553-03-7 SDS

553-03-7Relevant articles and documents

Dehydrogenative and Redox-Neutral N-Heterocyclization of Aminoalcohols Catalyzed by Manganese Pincer Complexes

Brzozowska, Aleksandra,Rueping, Magnus,Sklyaruk, Jan,Zubar, Viktoriia

, (2022/03/17)

A new manganese catalyzed heterocyclization of aminoalcohols has been accomplished. A wide range of heterocycles were synthesized, including 1,2,3,4-tetrahydroquinolines, dihydroquinolinones, and 2,3,4,5-tetrahydro-1H-benzo[b]azepines. The reaction is performed under mild reaction conditions using air and moisture stable manganese catalysts. The desired heterocycles were obtained in good to excellent yields.

DMSO/t-BuONa/O2-Mediated Aerobic Dehydrogenation of Saturated N-Heterocycles

Cai, Hu,Tan, Wei,Xie, Yongfa,Yang, Ruchun,Yue, Shusheng

, p. 7501 - 7509 (2020/07/07)

Aromatic N-heterocycles such as quinolines, isoquinolines, and indolines are synthesized via sodium tert-butoxide-promoted oxidative dehydrogenation of the saturated heterocycles in DMSO solution. This reaction proceeds under mild reaction conditions and has a good functional group tolerance. Mechanistic studies suggest a radical pathway involving hydrogen abstraction of dimsyl radicals from the N-H bond or α-C-H of the substrates and subsequent oxidation of the nitrogen or α-aminoalkyl radicals.

Formal Deoxygenative Hydrogenation of Lactams Using PNHP-Pincer Ruthenium Complexes under Nonacidic Conditions

Ogata, Osamu,Nara, Hideki,Matsumura, Kazuhiko,Kayaki, Yoshihito

supporting information, p. 9954 - 9959 (2019/12/24)

A formal deoxygenative hydrogenation of amides to amines with RuCl2(NHC)(PNHP) (NHC = 1,3-dimethylimizadol-2-ylidene, PNHP = bis(2-diphenylphosphinoethyl)amine) is described. Various secondary amides, especially NH-lactams, are reduced with H2 (3.0-5.0 MPa) to amines at a temperature range of 120-150 °C with 1.0-2.0 mol % of PNHP-Ru catalysts in the presence of Cs2CO3. This process consists of (1) deaminative hydrogenation of secondary amides to generate primary amines and alcohols, (2) dehydrogenative coupling of the transient amines with alcohols to generate imines, and (3) hydrogenation of imines to give the formally deoxygenated secondary amine products.

Multi-Functional Oxidase Activity of CYP102A1 (P450BM3) in the Oxidation of Quinolines and Tetrahydroquinolines

Li, Yushu,Wong, Luet L.

supporting information, p. 9551 - 9555 (2019/08/06)

Tetrahydroquinoline, quinoline, and dihydroquinolinone are common core motifs in drug molecules. Screening of a 48-variant library of the cytochrome P450 enzyme CYP102A1 (P450BM3), followed by targeted mutagenesis based on mutation-selectivity correlations from initial hits, has enabled the hydroxylation of substituted tetrahydroquinolines, quinolines, and 3,4-dihydro-2-quinolinones at most positions around the two rings in good to high yields at synthetically relevant scales (1.5 g L?1 day?1). Other oxidase activities, such as C?C bond desaturation, aromatization, and C?C bond formation, were also observed. The enzyme variants, with mutations at the key active site residues S72, A82, F87, I263, E267, A328, and A330, provide direct and sustainable routes to oxy-functionalized derivatives of these building block molecules for synthesis and drug discovery.

Enabling CO Insertion into o-Nitrostyrenes beyond Reduction for Selective Access to Indolin-2-one and Dihydroquinolin-2-one Derivatives

Yang, Li,Shi, Lijun,Xing, Qi,Huang, Kuo-Wei,Xia, Chungu,Li, Fuwei

, p. 10340 - 10348 (2018/10/20)

The transition metal-catalyzed reductive cyclization of o-nitrostyrene in the presence of carbon monoxide (CO) has been developed to be a general synthetic route to an indole skeleton, wherein CO was used as a reductant to deoxidize nitroarene into nitrosoarene and/or nitrene with CO2 release, but the selective insertion of CO into the heterocyclic product with higher atom economy has not yet been realized. Herein, the Pd-catalyzed reduction of o-nitrostyrene by CO and its regioselective insertion were efficiently achieved to produce synthetically useful five- and six-membered benzo-fused lactams. Detailed investigations revealed that the chemoselectivity to indole or lactam was sensitive to the nature of the counteranions of Pd2+ precursors, whereas ligands significantly decided the carbonylative regioselectivity by different reaction pathways. Using PdCl2/PPh3/B(OH)3 (condition A), an olefin hydrocarboxylation was primarily initiated followed by partial reduction of the NO2 moiety and cyclization reaction to give N-hydroxyl indolin-2-one, which was further catalytically reduced by CO to afford the indolin-2-one as the final product with up to 95% yield. When the reaction was conducted under the Pd(TFA)2/BINAP/TsOH·H2O system (condition B), complete deoxygenation and carbonylation of the NO2 group occurred initially to yield the corresponding isocyanate followed by internal hydrocyclization to generate 3,4-dihydroquinolin-2-one with up to 98% yield. Importantly, the methodology could be efficiently applied in the synthesis of marketed drug Aripiprazole.

Supported Gold Nanoparticles for Efficient α-Oxygenation of Secondary and Tertiary Amines into Amides

Jin, Xiongjie,Kataoka, Kengo,Yatabe, Takafumi,Yamaguchi, Kazuya,Mizuno, Noritaka

supporting information, p. 7212 - 7217 (2016/07/06)

Although the α-oxygenation of amines is a highly attractive method for the synthesis of amides, efficient catalysts suited to a wide range of secondary and tertiary alkyl amines using O2as the terminal oxidant have no precedent. This report describes a novel, green α-oxygenation of a wide range of linear and cyclic secondary and tertiary amines mediated by gold nanoparticles supported on alumina (Au/Al2O3). The observed catalysis was truly heterogeneous, and the catalyst could be reused. The present α-oxygenation utilizes O2as the terminal oxidant and water as the oxygen atom source of amides. The method generates water as the only theoretical by-product, which highlights the environmentally benign nature of the present reaction. Additionally, the present α-oxygenation provides a convenient method for the synthesis of18O-labeled amides using H218O as the oxygen source.

Imidazole derivatives as accelerators for ruthenium-catalyzed hydroesterification and hydrocarbamoylation of alkenes: Extensive ligand screening and mechanistic study

Konishi, Hideyuki,Muto, Takashi,Ueda, Tsuyoshi,Yamada, Yayoi,Yamaguchi, Miyuki,Manabe, Kei

, p. 836 - 845 (2015/03/14)

Imidazole derivatives are effective ligands for promoting the [Ru3(CO)12]-catalyzed hydroesterification of alkenes using formates. Extensive ligand screening was performed to identify 2-hydroxymethylated imidazole as the optimal ligand. Neither carbon monoxide gas nor a directing group was required, and the reaction also showed a wide substrate generality. The Ru-imidazole catalyst system also promoted intramolecular hydrocarbamoylation to afford lactams. A Ru-imidazole complex was unambiguously analyzed by X-ray crystallography, and it had a trinuclear structure derived from one [Ru3(CO)12] and two ligands. This complex was also successfully used for hydroesterification. The mechanism was examined in detail by using D- and 13C-labeled formates, indicating that the hydroesterification reaction proceeds by a decarbonylation-recarbonylation pathway. Effective imidazole assistant: [Ru3(CO)12]-catalyzed hydroesterification of alkenes by using formates is drastically accelerated by imidazole derivatives and exhibits a broad substrate scope for both alkenes and formates. The Ru-imidazole complex also catalyzes the intramolecular hydrocarbamoylation of alkenes.

Regiodivergent access to five- and six-membered benzo-fused lactams: Ru-catalyzed olefin hydrocarbamoylation

Li, Bin,Park, Yoonsu,Chang, Sukbok

supporting information, p. 1125 - 1131 (2014/02/14)

We report herein a new strategy of the Ru-catalyzed intramolecular olefin hydrocarbamoylation for the regiodivergent synthesis of five- and six-membered benzo-fused lactams starting from N-(2-alkenylphenyl)formamides. Using a combined catalyst of Ru3

Multicomponent multicatalyst reactions (MC)2R: One-pot synthesis of 3,4-dihydroquinolinones

Zhang, Lei,Sonaglia, Lorenzo,Stacey, Jason,Lautens, Mark

, p. 2128 - 2131 (2013/06/05)

A Rh/Pd/Cu catalyst system led to an efficient synthesis of dihydroquinolinones in one-pot, two operations. The reaction features the first triple metal-catalyzed transformations in one reaction vessel, without any intermediate workup. The conjugate-addition/amidation/amidation reaction sequence is highly modular, divergent, and practical.

A nitrophenyl-based prodrug type for colorectal targeting of prednisolone, budesonide and celecoxib

Marquez Ruiz, Juan F.,Kedziora, Kinga,Pigott, Maria,Keogh, Brian,Windle, Henry,Gavin, Jason,Kelleher, Dermot P.,Gilmer, John F.

, p. 1693 - 1698 (2013/04/10)

Celecoxib is a COX-2 inhibitor drug that can be used to reduce the risk of colorectal adenocarcinoma. Glucocorticoids are used in the treatment of inflammatory bowel disease. A limitation to the use of both drug types is that they undergo absorption from the intestinal tract with serious side effects. The prodrug systems introduced here involve forming a nitro-substituted acylsulfonamide group in the case of celecoxib and a nitro-substituted 21-ester for the glucocorticoids. Drug release is triggered by the nitro reductase action of the colonic microflora, liberating a cyclization competent species. The release of the active parent drugs was evaluated in vitro using Clostridium perfringens and epithelial transport through Caco-2 monolayer evaluation was carried out to estimate the absorption properties of the prodrugs compared to the parental drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 553-03-7